Description
Kenalog (Triamcinolone) Suspension for Injections 40 mg/ml, Ampoules 1ml, N5
Composition
The main active ingredient in Kenalog is triamcinolone acetonide, a corticosteroid.
Mechanism of Action
Triamcinolone acetonide exerts its pharmacological effects by inhibiting the inflammatory response through various mechanisms, including suppression of migration of polymorphonuclear leukocytes and reversal of increased capillary permeability.
Pharmacological Properties
Kenalog possesses potent anti-inflammatory, immunosuppressive, and vasoconstrictive properties. It helps in reducing inflammation, swelling, redness, and itching associated with various conditions.
Indications for Use
Kenalog is indicated for the treatment of allergic disorders, dermatologic conditions, ulcerative colitis, arthritis, systemic lupus erythematosus, psoriasis, and respiratory disorders where corticosteroid therapy is appropriate.
Contraindications
Kenalog is contraindicated in patients with known hypersensitivity to triamcinolone acetonide or any of the components of the formulation. It should not be used in patients with systemic fungal infections.
Side Effects
Common side effects of Kenalog may include injection site reactions, skin thinning, discoloration, acne, increased hair growth, and systemic effects such as adrenal suppression or Cushing’s syndrome with prolonged use.
Usage Instructions
Kenalog should be administered via intramuscular or intra-articular injection by a qualified healthcare professional. The dosage and frequency of administration should be individualized based on the patient’s condition and response to treatment.
Benefits Compared to Analogs
Kenalog offers the advantage of a long duration of action, requiring less frequent dosing compared to some other corticosteroids. Its high potency allows for effective symptom control with lower doses.
Suitable Patient Groups
Kenalog can be used in various patient populations, including adults, children, and the elderly. However, caution is advised in the elderly due to the potential for increased susceptibility to systemic side effects.
Storage and Shelf Life
Kenalog should be stored at controlled room temperature between 20°C to 25°C (68°F to 77°F). Protect from light. The shelf life of the product is as indicated on the packaging.
Packaging Description
Kenalog is available in ampoules containing 1ml of suspension for injections, with each pack containing 5 ampoules. The packaging should be checked for integrity before use.
